Ledger.Open graph →
SEC Form D · filed December 31, 2012

Ultragenyx Pharmaceutical Inc

Offering
$75.0M
Sold
$75.0M
Exemption
—
Industry
Biotechnology
Location
NOVATO, CA
Type
—

People & firms on this filing (13)

William Aliski · Novato, CADirectorShalini Sharp · New York, NYExecShalini Sharp · DURHAM, NCExecJohn Ditton · Novato, CAExecVimal Srivastava · NOVATO, CAExecThomas Kassberg · NOVATO, CAExecSteven Jungles · NOVATO, CAExecEmil D. Kakkis · NOVATO, CAExec · DirectorEran Nadav · Sandy Hook, CTDirectorBen Auspitz · DURHAM, NCDirectorMarten Steen · NOVATO, CADirectorCordelia Leonard · NOVATO, CAExecBen Auspitz · Bozeman, MTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗